Ionis Pharmaceuticals IONS Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's accounts payable?
- Ionis Pharmaceuticals (IONS) reported accounts payable of $26.03M in Q1 2026.
- How has Ionis Pharmaceuticals's accounts payable changed year-over-year?
- Ionis Pharmaceuticals's accounts payable increased by 49.1% year-over-year, from $17.46M to $26.03M.
- What is the long-term trend for Ionis Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's accounts payable has grown at a 10.3% compound annual growth rate (CAGR), from $17.2M to $28.08M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods or services already received.
- How do you interpret accounts payable?
- An increase may suggest improved cash management or delayed payments, while a decrease indicates faster settlement of obligations.
- How does accounts payable compare across companies?
- Standard metric for assessing short-term liabilities and cash flow management efficiency.